131 JX-594, A TARGETED MULTI-MECHANISTIC ONCOLYTIC POXVIRUS, IS WELL-TOLERATED AND EXHIBITS ANTI-TUMOR ACTIVITY IN PATIENTS WITH PRIMARY LIVER CANCER AND LIVER METASTASES

Autor: Heo, J., Cho, M., Reid, T., Lim, H.Y., Ruo, L., Kim, C.W., Bloomston, M., Rhee, B.-G., Oh, S.Y., Park, B.-H., Chung, H.C., Patt, R., Breitbach, C., Hwang, T.-H., Bell, J.C., Kirn, D.H.
Zdroj: In Journal of Hepatology March 2011 54 Supplement 1:S58-S58
Databáze: ScienceDirect